Wallace Pharmaceuticals

Reuters - November 23, 2009 4:33 AM

NOVATO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate ...

Forbes.com - November 23, 2009 4:19 AM

NOVATO, Calif. (Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO ) The objective of the single center, double-blind, randomized study conducted by Dr. Wallace was to demonstrate that the orally administered prodrug NGX426, maintains the ...

Forbes.com - November 04, 2009 5:38 PM

NOVATO, Calif. (Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO Mark Wallace, M.D., Professor of Clinical Anesthesiology at the Center for Pain Medicine of the University of California at San Diego ('UCSD') will present results from a ...

Reuters - November 04, 2009 4:57 PM

Proof-of-Concept Data at 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain NOVATO, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP), today announced that data from a clinical trial of ...